Novel and specialized medicines enable patients to improve their quality of life. Injection and administration into the body is a key component of adherence. Through innovation and development, the "injection experience" is constantly being optimized. Discover how we apply this as a service in our product development.
Today’s changing drug delivery landscape has fueled fast-growing demand for new approaches that meet evolving user needs. With Vetter’s specialized position in the value chain, our experts are uniquely able to translate these emerging demands into viable solutions for both biopharma organizations and the healthcare system.
Our Product Development & Design service focuses on identifying new opportunities to innovate drug delivery, translating early-stage ideas into user-centric concepts, and developing those promising concepts into regulator-ready assets for Vetter.
The goal: new technical and operational advances that solve user challenges and create new value for Vetter and the market.
For our multidisciplinary team of experts, new ideas can come from many different sources: customer projects, workshops, hackathons, industry and technology scouting, and more. We also actively engage with startups and innovation labs to gather their outside perspective and leverage their fresh thinking on real user/patients challenges we can potentially solve.
Once we identify ideas with traction, we move quickly to define the challenge, establish essential user requirements, and create a target profile that can be vetted with key stakeholders. Even in this early stage, we don’t wait to think about implementation: each new concept is carefully assessed for viability, feasibility, and market desirability.
User-centric prototyping and testing are essential features of our development process. Once we select a concept that promises to solve real-world challenges, we regularly conduct qualitative and quantitative assessments of its utility, usability, and potential to generate valuable intellectual property (IP).
Users and potential customers are engaged as early and often as possible during these early development processes. Their feedback provides critical guidance for our proactive, iterative approach, including user and design requirements, manufacturing concepts, prototypes, and more.
With a concept defined, requirements captured, and stakeholders aligned, we begin a rigorous, ISO 13485-certified development process– one that transforms our ideas into value-generating assets. Design controls, de-risking strategies, and human factors assessments are implemented at every step, along with detailed monitoring of project budgets and milestones.
The final output: new products, processes, services, and business models that can be added to our growing innovation portfolio. To complete its development cycle, each asset must achieve an optimal balance of market viability, technical feasibility, and user/customer desirability – a clear sign that it can meaningfully advance drug delivery to the benefit of the patient.
